超声衰减成像在活检证实的非酒精性脂肪性肝病队列中的定量诊断
这项前瞻性研究纳入60例临床怀疑非酒精性脂肪性肝病并接受肝活检的患者,评估超声衰减成像(ATI)检测肝脂肪变性的效能。ATI检测≥S1、≥S2和S3的AUC分别为0.968、0.911和0.766,与受控衰减参数(CAP)相比诊断价值无显著差异(P分别为.281、.254和.330)。ATI显示出良好的可行性和诊断效能。
要点
- ATI检查成功率100%,观察者内重复性为0.981。
- ATI检测≥S1的AUC为0.968, cut-off值为0.671 dB/cm/MHz。
- ATI与CAP在检测≥S1、≥S2和S3时诊断价值无显著差异。
核心结论
- ATI在检测非酒精性脂肪性肝病患者不同程度肝脂肪变性方面显示出良好的可行性和诊断效能。
研究设计与样本
- 前瞻性研究,纳入60例临床怀疑非酒精性脂肪性肝病并在2020年9月至2021年12月间接受ATI和CAP检查后转诊肝活检的患者,以组织学肝脂肪变性分级为参考标准。
诊断标准与关键数值
- ATI检测≥S1的AUC为0.968, cut-off值为0.671 dB/cm/MHz。
- ATI检测≥S2的AUC为0.911, cut-off值为0.726 dB/cm/MHz。
- ATI检测S3的AUC为0.766, cut-off值为0.757 dB/cm/MHz。
- CAP检测≥S1的AUC为0.916, cut-off值为258.5 dB/m。
- CAP检测≥S2的AUC为0.872, cut-off值为300.0 dB/m;检测S3的AUC为0.807, cut-off值为315.0 dB/m。
临床应用与阅片要点
- ATI检查成功率为100%,观察者内重复性为0.981。
- ATI与CAP在检测≥S1、≥S2和S3时诊断价值无显著差异(P分别为.281、.254和.330)。
- ATI与高密度脂蛋白胆固醇(P < .001)和甘油三酯(P = .015)存在显著相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the performance of attenuation imaging (ATI) based on ultrasound for detection of hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD).
MATERIALS AND METHODS: This prospective study was approved by our institutional review board (B2021-092R). Written informed consent was obtained from all patients. This study included 60 patients who had clinical suspicion of NAFLD and were referred for liver biopsy after ATI and controlled attenuation parameter (CAP) examinations between September 2020 and December 2021. The histologic hepatic steatosis was graded. The area under curve (AUC) analysis was performed.
RESULTS: The success rate of the ATI examination was 100%. The intraobserver reproducibility of ATI was 0.981. The AUCs of ATI for detecting ≥S1, ≥S2, and S3 were 0.968 (cut-off value of 0.671 dB/cm/MHz), 0.911 (cut-off value of 0.726 dB/cm/MHz), and 0.766 (cut-off value of 0.757 dB/cm/MHz), respectively. The AUCs of CAP for detecting ≥S1, ≥S2, and S3 were 0.916 (cut-off value of 258.5 dB/m), 0.872 (cut-off value of 300.0 dB/m), and 0.807 (cut-off value of 315.0 dB/m), respectively. The diagnostic values showed no significant difference between ATI and CAP in detecting ≥S1, ≥S2, and S3 (P = .281, P = .254, and P = .330, respectively). The ATI had significant correlations with high-density lipoprotein cholesterol (P < .001), and with triglycerides (P = .015).
CONCLUSION: ATI showed good feasibility and diagnostic performance in the detection of varying degrees of hepatic steatosis in NAFLD patients.
引用
- Huang, Bian, Zhu, et al. Quantitative Diagnosis of Nonalcoholic Fatty Liver Disease with Ultrasound Attenuation Imaging in a Biopsy-Proven Cohort. Acad Radiol. 2023. PMID: 37407373. doi:10.1016/j.acra.2023.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。